Roche to Pay Enzo $21 Million to Settle Patent Infringement Suit
February 11 2019 - 2:51PM
Dow Jones News
By Patrick Thomas
Roche Holdings Ltd. (RHHBY) will pay $21 million patent
infringement settlement to Enzo Biochem Inc., Enzo said in a filing
with the U.S. Securities and Exchange Commission Monday.
In its 2012 lawsuit, Enzo, a biotechnology company, said that
Roche sold certain nucleic acid products in the U.S. used for
genetic testing for diseases. The settlement, agreed on by the
companies last week, involves several of Roche Holdings'
subsidiaries, Roche Diagnostics GmbH and Roche Molecular Systems
that make medical equipment.
Enzo said in the filing that this settlement doesn't affect its
civil action for patent infringement against Roche in the U.S.
District Court for the State of Delaware.
Representatives from Enzo and Roche couldn't be immediately
reached for comment.
Write to Patrick Thomas at patrick.thomas@wsj.com
(END) Dow Jones Newswires
February 11, 2019 14:36 ET (19:36 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Enzo Biochem (NYSE:ENZ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Enzo Biochem (NYSE:ENZ)
Historical Stock Chart
From Sep 2023 to Sep 2024